tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

BYSI Stock Latest News

BeyondSpring presents efficacy results from Phase 2 IIT study of plinabulin
The FlyBeyondSpring presents efficacy results from Phase 2 IIT study of plinabulin
1M ago
BYSI
BeyondSpring presents final data analysis of DUBLIN-3 Phase 3 study
PremiumThe Fly
BeyondSpring presents final data analysis of DUBLIN-3 Phase 3 study
3M ago
BYSI
BeyondSpring presented interim Phase 2 data on 303 Study
PremiumThe Fly
BeyondSpring presented interim Phase 2 data on 303 Study
3M ago
MRK
BYSI
BeyondSpring announces Dublin-3 final phase 3 efficacy data
PremiumThe Fly
BeyondSpring announces Dublin-3 final phase 3 efficacy data
3M ago
BYSI
BeyondSpring Inc. Reports Mid-Year Financials
PremiumCompany Announcements
BeyondSpring Inc. Reports Mid-Year Financials
4M ago
6K
BYSI
SEED and Eisai Partner on Groundbreaking Biotech Research
PremiumCompany AnnouncementsSEED and Eisai Partner on Groundbreaking Biotech Research
5M ago
6K
BYSI
SEED Therapeutics enters strategic research collab with Eisai
Premium
The Fly
SEED Therapeutics enters strategic research collab with Eisai
5M ago
BYSI
BeyondSpring files to sell 10M ordinary shares
Premium
The Fly
BeyondSpring files to sell 10M ordinary shares
6M ago
BYSI
BeyondSpring Inc. Announces Share Issuance
PremiumCompany Announcements
BeyondSpring Inc. Announces Share Issuance
6M ago
6K
BYSI
BeyondSpring announces R&D day on new Plinabulin strategy
PremiumThe Fly
BeyondSpring announces R&D day on new Plinabulin strategy
7M ago
BYSI
BeyondSpring reports first patient dosed with pembrolizumab, plinabulin plus EP
PremiumThe Fly
BeyondSpring reports first patient dosed with pembrolizumab, plinabulin plus EP
9M ago
BYSI
BeyondSpring Announces Executive Leadership Change
PremiumCompany Announcements
BeyondSpring Announces Executive Leadership Change
9M ago
6K
BYSI
BeyondSpring regains compliance with Nasdaq minimum bid price rule
PremiumThe FlyBeyondSpring regains compliance with Nasdaq minimum bid price rule
10M ago
BYSI
BeyondSpring reports Nasdaq delinquency notice for late filing
Premium
The Fly
BeyondSpring reports Nasdaq delinquency notice for late filing
12M ago
BYSI
BeyondSpring receives noncompliance notification from Nasdaq
Premium
The Fly
BeyondSpring receives noncompliance notification from Nasdaq
1y ago
BYSI
BeyondSpring presents new data on plinabulin’s immunomodulating activity
PremiumThe Fly
BeyondSpring presents new data on plinabulin’s immunomodulating activity
1y ago
BYSI
BeyondSpring presents poster on plinabulin’s anti-cancer efficacy
PremiumThe Fly
BeyondSpring presents poster on plinabulin’s anti-cancer efficacy
1y ago
BYSI
BeyondSpring regains compliance with Nasdaq minimum bid price rule
PremiumThe Fly
BeyondSpring regains compliance with Nasdaq minimum bid price rule
1y ago
BYSI
BeyondSpring’s Seed Therapeutics discloses IND candidate, ST-00937
PremiumThe Fly
BeyondSpring’s Seed Therapeutics discloses IND candidate, ST-00937
1y ago
BYSI
BeyondSpring receives noncompliance notification from Nasdaq
PremiumThe FlyBeyondSpring receives noncompliance notification from Nasdaq
1y ago
BYSI
BeyondSpring’s SEED Therapeutics appoints Tai to board of directors
Premium
The Fly
BeyondSpring’s SEED Therapeutics appoints Tai to board of directors
2y ago
LLY
BYSI
BeyondSpring price target lowered to $1.25 from $4 at Baird
Premium
The Fly
BeyondSpring price target lowered to $1.25 from $4 at Baird
2y ago
BYSI

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >